Інформація призначена тільки для фахівців сфери охорони здоров'я, осіб,
які мають вищу або середню спеціальну медичну освіту.

Підтвердіть, що Ви є фахівцем у сфері охорони здоров'я.

International journal of endocrinology 5 (45) 2012

Back to issue

Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGER

Authors: Karlson B.W., Barter P.J., Palmer M.K. et al.

Categories: Endocrinology

Sections: Specialist manual

print version

Background and aims. Diabetes mellitus is a well-known risk factor for cardiovascular disease, and brings an increased risk of vascular events and a higher mortality rate. Treatment guidelines recommend statins in patients with diabetes, with low-density lipoprotein cholesterol (LDL-C) targets of 100 mg/dl (~2.5 mmol/l), and 80 (~2.0 mmol/l) or 70 mg/dl (~1.8 mmol/l) in especially high-risk patients. The current study used the VOYAGER (an indiVidual patient data-meta-analysis Of statin therapY in At risk Groups: Effects of Rosuvastatin, atorvastatin, and simvastatin) database to characterise effects of rosuvastatin, atorvastatin and simvastatin in different doses on lipid levels in diabetes patients.

Methods and results. The VOYAGER database included individual patient data from 37 studies involving comparisons of rosuvastatin with either atorvastatin or simvastatin. Of the 32 258 patients included, 8859 (27.5 %) had diabetes. Rosuvastatin appeared to be the most efficacious of the three statins, both for lowering LDL-C and for reaching a target level of < 70 mg/dl for LDL-C. It was also more effective than atorvastatin at raising high-density lipoprotein cholesterol in the diabetes population. These results are consistent with the overall VOYAGER results.

Conclusions. This meta-analysis of 8859 patients with diabetes mellitus shows favourable effects on lipids with the three statins studied, in line with results for the overall VOYAGER population. The importance of using an effective statin at an effective dose to reach treatment goals for such high-risk patients is evident.

Metabolism and Cardiovascular Diseases. — June 2012

Similar articles

Эффективность и безопасность комбинированной гиполипидемической терапии эзетимибом и аторвастатином у пациентов с острым инфарктом миокарда
Authors: Лутай Я.М., Иркин О.И., Степура А.А., Белый Д.А., Пархоменко А.Н. - ГУ «ННЦ «Институт кардиологии имени академика Н.Д. Стражеско» НАМН Украины, отдел реанимации и интенсивной терапии
"Emergency medicine" 3 (58) 2014
Date: 2014.06.17
Categories: Medicine of emergency, Cardiology
Sections: Clinical researches
Very severe hypertriglyceridemia in a subject with poor glycemic control: a case report with general consideration
Authors: E. Xhardo, F. Agaçi
Department of Internal Medicine, University Hospital “Shefqet Ndroqi”, Tirana, Albania

International journal of endocrinology Том 16, №2, 2020
Date: 2020.05.06
Categories: Endocrinology
Sections: Specialist manual

Back to issue